HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Bengtsson Selected Research

ensifentrine

1/2021A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy.
2/2020A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD.
1/2020Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis.
11/2018The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Bengtsson Research Topics

Disease

10Asthma (Bronchial Asthma)
01/2022 - 10/2004
10Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 12/2005
4Neoplasms (Cancer)
01/2020 - 02/2012
2Multiple Sclerosis
01/2022 - 01/2022
2COVID-19
11/2021 - 01/2021
2Inflammation (Inflammations)
01/2021 - 02/2010
2Cough
01/2013 - 12/2005
1Disease Progression
01/2022
1Oral Lichen Planus
01/2022
1Atrophy
01/2022
1Ulcer
01/2022
1Common Cold
01/2021
1Human Influenza (Influenza)
01/2021
1Fever (Fevers)
01/2021
1Dyspnea (Shortness of Breath)
01/2020
1Amyloid Plaque
09/2019
1Alzheimer Disease (Alzheimer's Disease)
09/2019
1Bronchial Spasm
03/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2012
1Lung Neoplasms (Lung Cancer)
04/2012
1Rhinitis
02/2010
1Seasonal Allergic Rhinitis (Hay Fever)
02/2010
1Tremor (Tremors)
10/2004

Drug/Important Bio-Agent (IBA)

9Formoterol Fumarate (Oxis)FDA Link
01/2022 - 10/2004
7Pharmaceutical PreparationsIBA
01/2022 - 04/2012
6Bronchodilator Agents (Bronchodilators)IBA
02/2020 - 12/2005
5Terbutaline (Brethaire)FDA LinkGeneric
01/2018 - 10/2004
4Budesonide (Pulmicort)FDA LinkGeneric
01/2022 - 05/2008
4Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2021 - 11/2018
4ensifentrineIBA
01/2021 - 11/2018
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2012
2ocrelizumabIBA
01/2022 - 01/2022
2Tiotropium Bromide (Spiriva)FDA Link
01/2021 - 01/2013
2AZD9164IBA
03/2014 - 01/2013
2Blood Glucose (Blood Sugar)IBA
06/2012 - 02/2012
2Glucose (Dextrose)FDA LinkGeneric
06/2012 - 02/2012
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2012 - 04/2012
1Clobetasol (Clobetasol Propionate)FDA LinkGeneric
01/2022
1compound 21IBA
11/2021
1VaccinesIBA
11/2021
1Type 2 Angiotensin ReceptorIBA
11/2021
1Oxygen (Dioxygen)IBA
01/2021
1SteroidsIBA
01/2021
1GlucocorticoidsIBA
01/2021
1tau Proteins (tau Protein)IBA
09/2019
1Monoamine Oxidase (MAO)IBA
09/2019
1(18F)GTP1IBA
09/2019
1Proteins (Proteins, Gene)FDA Link
09/2019
1Albuterol (Salbutamol)FDA LinkGeneric
11/2018
1Ipratropium (Ipratropium Bromide)FDA LinkGeneric
11/2018
1Methacholine Chloride (Methacholine)FDA Link
01/2018
1Citric Acid (Citrate)FDA LinkGeneric
03/2014
1BuffersIBA
03/2014
1Adrenergic Receptors (Adrenergic Receptor)IBA
10/2013
1Muscarinic AntagonistsIBA
01/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2012
1AllergensIBA
02/2010
1CC ChemokinesIBA
02/2010
1Histamine Antagonists (Antihistamines)IBA
02/2010
1Loratadine (Alavert)FDA Link
02/2010
1Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
02/2010
1Tryptases (Tryptase)IBA
02/2010
13- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
05/2006

Therapy/Procedure

4Therapeutics
01/2022 - 12/2005
3Dry Powder Inhalers
05/2008 - 04/2005
1Nebulizers and Vaporizers (Inhaler)
01/2022